See also this year's filing and all EDGAR filings for this company.
PDF Report 0001472174_2012_Phyhealth_Corp.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001472174, Phyhealth Corp
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 11,433 |
| 2 | AssetsCurrent | 125,693 |
| 3 | PropertyPlantAndEquipment | 204,389 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 719,312 |
| 7 | remainder_Liabilities | 97,960 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 439,214 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 618,086 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 870,221 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | -341,269 |
| 19 | remainder_ComprehensiveNetIncome | -162,241 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 341,515 |
| 1 | Liabilities | 817,272 |
| 2 | Expenses | 1,927,521 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -475,757 |
| 5 | NetIncome | -2,268,790 |
| 6 | ComprehensiveNetIncome | -2,431,031 |
| 7 | BaseVar | 1,794,909 |
| 8 | EconomicCapitalRatio | -6.48 |
Edgar->Model Mapping
Feature Distribution
